Recent Annual Reports

Browse the latest SEC filings with AI-powered analysis. Get insights into corporate performance, financial trends, and business developments.

📊 5202 Reports

🤖 AI Analyzed

Recent

📄 Page 337 of 434

Viridian Therapeutics, Inc.\DE

10-K February 26, 2026

Key Highlights

Accelerated R&D with lead programs VRDN-123 (Phase 2b enrollment completed) and ...
Collaboration revenue increased to $15 million, validating the company's platfor...
Strong cash position of $250 million provides funding runway into late 2027, wit...

Read Analysis

🤖 AI Generated

NAVIENT CORP

10-K February 26, 2026

Key Highlights

Strong growth and diversification from the Business Processing segment, offsetti...
Disciplined capital management, including significant debt reduction and improve...
Consistent return of capital to shareholders through share repurchases and divid...

Read Analysis

🤖 AI Generated

Moelis & Co

10-K February 26, 2026

Key Highlights

Premier global independent investment bank providing expert, unbiased advice.
Maintains a robust financial position with strong cash and no long-term debt, of...
Demonstrated resilience in a challenging M&A market, with growth in restructurin...

Read Analysis

🤖 AI Generated

DNOW Inc.

10-K February 26, 2026

Key Highlights

DNOW Inc. reported strong 2023 financial performance with 5% revenue growth to $...
The company maintained robust financial health, ending 2023 with $210 million in...
Strategic initiatives included expanding digital offerings, completing a key acq...

Read Analysis

🤖 AI Generated

Aurinia Pharmaceuticals Inc.

10-K February 26, 2026

Key Highlights

Aurinia achieved 35% revenue growth in 2025, reaching $210 million, primarily dr...
The company holds a strong cash and investments position of $280 million with no...
Initiated a Phase 2 clinical trial for a potential new indication for voclospori...

Read Analysis

🤖 AI Generated

Stellantis N.V.

20-F February 26, 2026

Key Highlights

Robust 2024 financial performance with €18.6 billion net profit and a 12.8% Adju...
Aggressive 'Dare Forward 2030' strategic plan focusing on electrification, softw...
Significant investments in future technologies, including €4.1 billion in batter...

Read Analysis

🤖 AI Generated

National Storage Affiliates Trust

10-K February 26, 2026

Key Highlights

Robust financial performance with 11.8% total revenue growth and 15% net income ...
Strategic portfolio expansion, adding 85 new properties to exceed 1,200, driven ...
Strong operational efficiency demonstrated by 91.5% same-store occupancy and 7.2...

Read Analysis

🤖 AI Generated

NexPoint Residential Trust, Inc.

10-K February 26, 2026

Key Highlights

Achieved 6% revenue growth and maintained 94.5% occupancy rates in a dynamic mar...
Successfully executed value-add strategy, renovating over 1,500 units with 8-10%...
Strategically disposed of non-core assets for a $15 million gain, reinvesting in...

Read Analysis

🤖 AI Generated

Shake Shack Inc.

10-K February 26, 2026

Key Highlights

Strong revenue growth of 18% to $1.05 billion in FY2023, driven by 40 new Shacks...
Significant improvement in net income to $28 million and 25% Adjusted EBITDA gro...
Healthy balance sheet with $150 million in cash and a current ratio of 1.8, prov...

Read Analysis

🤖 AI Generated

Talen Energy Corp

10-K February 26, 2026

Key Highlights

Total operating revenues increased by 6% to $3.5 billion in 2025, driven by high...
Talen achieved a significant debt reduction of $220 million, lowering total debt...
Commodity contracts saw a positive turnaround, shifting from a $20 million unrea...

Read Analysis

🤖 AI Generated

Business First Bancshares, Inc.

10-K February 26, 2026

Key Highlights

Achieved robust financial growth in 2024, with total revenue up 22% to $325 mill...
Successfully completed two major acquisitions in 2024, adding over $1.25 billion...
Maintains strong capital adequacy (CET1 ratio 10.5%) and robust liquidity, well ...

Read Analysis

🤖 AI Generated

Indivior Pharmaceuticals, Inc.

10-K February 26, 2026

Key Highlights

Strong performance from Sublocade, a core product in opioid use disorder treatme...
Strategic streamlining of the product portfolio by discontinuing OPVEE and scali...
Initiated an 'Action Agenda Phase I' aimed at improving long-term profitability ...

Read Analysis

🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from annual reports with our AI-powered analysis. Track corporate performance, financial trends, and strategic developments.

Back to Homepage